ID

42903

Description

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT00484211

Link

https://clinicaltrials.gov/show/NCT00484211

Keywords

  1. 4/3/17 4/3/17 -
  2. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatocellular Carcinoma NCT00484211

Eligibility Hepatocellular Carcinoma NCT00484211

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients >18 years affected by advanced or metastatic hcc previously treated with no more than one systemic therapeutic regimen
Description

Age | systemic therapy Quantity Advanced Adult Hepatocellular Carcinoma | systemic therapy Quantity Metastatic hepatocellular carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C1706732
UMLS CUI [3,1]
C1515119
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0744869
histologically confirmed hcc not amenable to curative surgery
Description

Liver carcinoma Curative Surgery Amenable

Data type

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C1511562
UMLS CUI [1,3]
C3900053
child-pugh scale class a
Description

Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1]
C4050412
ecog performance status 0 - 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
patients in progression disease at study entry ct documented
Description

Disease Progression X-Ray Computed Tomography

Data type

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0040405
adequate baseline bone marrow, hepatic and renal function, defined as follows:
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
neutrophils > 1.5 x 10^9/l and platelets > 100 x 10^9/l
Description

Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
bilirubin < 2 x uln
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
transaminases < 3 x uln
Description

Transaminases

Data type

boolean

Alias
UMLS CUI [1]
C0002594
absence of any conditions in which hypervolaemia and its consequences (e.g. increased stroke volume, elevated blood pressure) or haemodilution could represent a risk for the patient (reference appendix "technical data sheet human albumin")
Description

Fluid overload | Increased cardiac stroke volume | Increase in blood pressure | Hemodilution | Patient Risk Absent

Data type

boolean

Alias
UMLS CUI [1]
C0546817
UMLS CUI [2]
C0520872
UMLS CUI [3]
C0497247
UMLS CUI [4]
C0019009
UMLS CUI [5,1]
C0030705
UMLS CUI [5,2]
C0035647
UMLS CUI [5,3]
C0332197
normal cardiac function and absence of uncontrolled hypertension
Description

Cardiac function | Uncontrolled hypertension Absent

Data type

boolean

Alias
UMLS CUI [1]
C0232164
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0332197
patients must give written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
decompensated cirrhosis (child-pugh score >7)
Description

Decompensated cirrhosis Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C1619727
UMLS CUI [1,2]
C4050412
concurrent anticancer therapy
Description

cancer treatment

Data type

boolean

Alias
UMLS CUI [1]
C0920425
patients may not receive any other investigational agents while on study
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
clinical signs of cns involvement
Description

Central Nervous System Involvement Sign or Symptom

Data type

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C3540840
patients with active or uncontrolled systemic disease/infections or with serious illness or medical conditions, which is incompatible with the protocol
Description

Systemic disease Uncontrolled | Sepsis Uncontrolled | Illness Serious Inconsistent Study Protocol | Medical condition Inconsistent Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0243026
UMLS CUI [2,2]
C0205318
UMLS CUI [3,1]
C0221423
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0442809
UMLS CUI [3,4]
C2348563
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0442809
UMLS CUI [4,3]
C2348563
known hypersensitivity/allergic reaction to human albumin preparations or to any of the excipients
Description

Hypersensitivity Human Albumin | Hypersensitivity Human Albumin Excipient | Allergic Reaction Human Albumin | Allergic Reaction Human Albumin Excipient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0304925
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0304925
UMLS CUI [2,3]
C0015237
UMLS CUI [3,1]
C1527304
UMLS CUI [3,2]
C0304925
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C0304925
UMLS CUI [4,3]
C0015237
any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol
Description

Mental condition Protocol Compliance Limited | Condition Familial Protocol Compliance Limited | Sociological Factors Protocol Compliance Limited | Geographic Factors Protocol Compliance Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C0525058
UMLS CUI [1,3]
C0439801
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0241888
UMLS CUI [2,3]
C0525058
UMLS CUI [2,4]
C0439801
UMLS CUI [3,1]
C3850138
UMLS CUI [3,2]
C0525058
UMLS CUI [3,3]
C0439801
UMLS CUI [4,1]
C0017444
UMLS CUI [4,2]
C0525058
UMLS CUI [4,3]
C0439801
pregnancy or lactation. patients - both males and females - with reproductive potential (i.e. menopausal for less than 1-year and not surgically sterilized) must practice effective contraceptive measures throughout the study. women of childbearing potential must provide a negative pregnancy test (serum or urine) within 14 days prior to registration
Description

Pregnancy | Breast Feeding | Females & males of reproductive potential Contraceptive methods | Postmenopausal state | Sexual sterilization | Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C4034483
UMLS CUI [3,2]
C0700589
UMLS CUI [4]
C0232970
UMLS CUI [5]
C0038288
UMLS CUI [6,1]
C3831118
UMLS CUI [6,2]
C0430061
UMLS CUI [7,1]
C3831118
UMLS CUI [7,2]
C0430057

Similar models

Eligibility Hepatocellular Carcinoma NCT00484211

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | systemic therapy Quantity Advanced Adult Hepatocellular Carcinoma | systemic therapy Quantity Metastatic hepatocellular carcinoma
Item
patients >18 years affected by advanced or metastatic hcc previously treated with no more than one systemic therapeutic regimen
boolean
C0001779 (UMLS CUI [1])
C1515119 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1706732 (UMLS CUI [2,3])
C1515119 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0744869 (UMLS CUI [3,3])
Liver carcinoma Curative Surgery Amenable
Item
histologically confirmed hcc not amenable to curative surgery
boolean
C2239176 (UMLS CUI [1,1])
C1511562 (UMLS CUI [1,2])
C3900053 (UMLS CUI [1,3])
Child-Pugh Classification
Item
child-pugh scale class a
boolean
C4050412 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0 - 1
boolean
C1520224 (UMLS CUI [1])
Disease Progression X-Ray Computed Tomography
Item
patients in progression disease at study entry ct documented
boolean
C0242656 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
Bone Marrow function | Liver function | Renal function
Item
adequate baseline bone marrow, hepatic and renal function, defined as follows:
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Absolute neutrophil count | Platelet Count measurement
Item
neutrophils > 1.5 x 10^9/l and platelets > 100 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Serum total bilirubin measurement
Item
bilirubin < 2 x uln
boolean
C1278039 (UMLS CUI [1])
Transaminases
Item
transaminases < 3 x uln
boolean
C0002594 (UMLS CUI [1])
Fluid overload | Increased cardiac stroke volume | Increase in blood pressure | Hemodilution | Patient Risk Absent
Item
absence of any conditions in which hypervolaemia and its consequences (e.g. increased stroke volume, elevated blood pressure) or haemodilution could represent a risk for the patient (reference appendix "technical data sheet human albumin")
boolean
C0546817 (UMLS CUI [1])
C0520872 (UMLS CUI [2])
C0497247 (UMLS CUI [3])
C0019009 (UMLS CUI [4])
C0030705 (UMLS CUI [5,1])
C0035647 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
Cardiac function | Uncontrolled hypertension Absent
Item
normal cardiac function and absence of uncontrolled hypertension
boolean
C0232164 (UMLS CUI [1])
C1868885 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
patients must give written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Decompensated cirrhosis Child-Pugh Classification
Item
decompensated cirrhosis (child-pugh score >7)
boolean
C1619727 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
cancer treatment
Item
concurrent anticancer therapy
boolean
C0920425 (UMLS CUI [1])
Investigational New Drugs
Item
patients may not receive any other investigational agents while on study
boolean
C0013230 (UMLS CUI [1])
Central Nervous System Involvement Sign or Symptom
Item
clinical signs of cns involvement
boolean
C4050309 (UMLS CUI [1,1])
C3540840 (UMLS CUI [1,2])
Systemic disease Uncontrolled | Sepsis Uncontrolled | Illness Serious Inconsistent Study Protocol | Medical condition Inconsistent Study Protocol
Item
patients with active or uncontrolled systemic disease/infections or with serious illness or medical conditions, which is incompatible with the protocol
boolean
C0442893 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0243026 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0221423 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0442809 (UMLS CUI [3,3])
C2348563 (UMLS CUI [3,4])
C3843040 (UMLS CUI [4,1])
C0442809 (UMLS CUI [4,2])
C2348563 (UMLS CUI [4,3])
Hypersensitivity Human Albumin | Hypersensitivity Human Albumin Excipient | Allergic Reaction Human Albumin | Allergic Reaction Human Albumin Excipient
Item
known hypersensitivity/allergic reaction to human albumin preparations or to any of the excipients
boolean
C0020517 (UMLS CUI [1,1])
C0304925 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0304925 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
C1527304 (UMLS CUI [3,1])
C0304925 (UMLS CUI [3,2])
C1527304 (UMLS CUI [4,1])
C0304925 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
Mental condition Protocol Compliance Limited | Condition Familial Protocol Compliance Limited | Sociological Factors Protocol Compliance Limited | Geographic Factors Protocol Compliance Limited
Item
any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol
boolean
C3840291 (UMLS CUI [1,1])
C0525058 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0241888 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C0439801 (UMLS CUI [2,4])
C3850138 (UMLS CUI [3,1])
C0525058 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])
C0017444 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
Pregnancy | Breast Feeding | Females & males of reproductive potential Contraceptive methods | Postmenopausal state | Sexual sterilization | Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative
Item
pregnancy or lactation. patients - both males and females - with reproductive potential (i.e. menopausal for less than 1-year and not surgically sterilized) must practice effective contraceptive measures throughout the study. women of childbearing potential must provide a negative pregnancy test (serum or urine) within 14 days prior to registration
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C4034483 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0232970 (UMLS CUI [4])
C0038288 (UMLS CUI [5])
C3831118 (UMLS CUI [6,1])
C0430061 (UMLS CUI [6,2])
C3831118 (UMLS CUI [7,1])
C0430057 (UMLS CUI [7,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial